tradingkey.logo
tradingkey.logo
Search

AngioDynamics Inc

ANGO
Add to Watchlist
12.120USD
+0.390+3.32%
Close 11-09 16:00(ET)
509.65MMarket Cap
LossP/E TTM

Today

+3.32%

5 Days

+3.06%

1 Month

+5.21%

6 Months

+8.21%

Year to Date

-5.61%

1 Year

+0.83%

Key Figures

12.025Open
12.190High
143.53KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.34%Turnover Ratio
11.730Prev. Close
11.520Low
1.73MTurnover
LossP/E Static
2.98P/B
0.00%Div Yield TTM
-11.50%ROA
16.29052wk High
0.20Volume Ratio
-33.99MNet Profit
42.05MShares
-0.7584EPS TTM
0.39Beta
-17.47%ROE
9.39052wk Low
5.71%Amplitude
56.00%Gross Margin
509.65MMarket Cap
6.31Reward/Risk
3.05%Risk Rate
Recent
Earnings
Transcripts
More news coming soon, stay tuned...

AngioDynamics Inc's Score

-0.26vs previous score
Forecast8.00
Financial Health7.36
Technical3.96
Valuation Dimensions7.29
Institutional Confidence10.00
Risk Assessment5.88

Media Coverage

Coverage Level

Very Low
Very High
Neutral

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
19.750Target Price
+64.72%Upside Space
Current Rating2026-112026-102026-092026-082026-072026-062026-052026-04
Strong Buy00000111
Buy44444433
Hold00000000
Sell00000000
Strong Sell00000000

AngioDynamics Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Neutral
Summary
Neutral
Moving Average
Neutral

AngioDynamics Inc Latest Earnings Call Transcripts

AngioDynamics (ANGO) Fiscal Q1 2027 Earnings Call: Med Tech Revenue Rises 13.2%

AngioDynamics fiscal Q1 2027 revenue rose 6.9% as Med Tech grew 13.2%. The company maintained its $336 million-$341 million annual sales guidance.

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2027Q1
Earnings / Forecast
-0.17/-0.11
Revenue / Forecast
80.92M/80.50M

AngioDynamics Inc Profile

SectorHealthcare Equipment & Supplies
Ticker SymbolANGO
Number of employees675
CountryUnited States of America

Ownership

ShareholdersProportion
BlackRock Institutional Trust Company, N.A.7.81%
Point72 Asset Management, L.P.6.84%
Systematic Financial Management, L.P.6.06%
Kotler (Kevin)5.86%
Shareholder TypesProportion
Investment Advisor39.21%
Investment Advisor/Hedge Fund27.36%
Hedge Fund19.75%
Individual Investor12.28%

FAQs

What is the current price of AngioDynamics Inc (ANGO)?

The current price of AngioDynamics Inc (ANGO) is 12.12.

What is the symbol of AngioDynamics Inc?

The ticker symbol of AngioDynamics Inc is ANGO.

What is the 52-week high of AngioDynamics Inc?

The 52-week high of AngioDynamics Inc is 16.29.

What is the 52-week low of AngioDynamics Inc?

The 52-week low of AngioDynamics Inc is 9.39.

What is the market capitalization of AngioDynamics Inc?

The market capitalization of AngioDynamics Inc is 509.65M.

Is AngioDynamics Inc (ANGO) currently rated as Buy, Hold, or Sell?

According to analysts, AngioDynamics Inc (ANGO) has an overall rating of Buy, with a price target of 19.75.

What is the Earnings Per Share (EPS TTM) of AngioDynamics Inc (ANGO)?

The Earnings Per Share (EPS TTM) of AngioDynamics Inc (ANGO) is -0.76.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.